Ferté C - Search Results

1

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.

Champiat S, Dercle L, Ammari S, Massard C, Hollebecque A, Postel-Vinay S, Chaput N, Eggermont A, Marabelle A, Soria JC, Ferté C. Champiat S, et al. Among authors: ferte c. Clin Cancer Res. 2017 Apr 15;23(8):1920-1928. doi: 10.1158/1078-0432.CCR-16-1741. Epub 2016 Nov 8. Clin Cancer Res. 2017. PMID: 27827313

2

Wound healing delay after central venous access following DCF/VEGF-trap therapy.

Ferté C, Massard C, Moldovan C, Desruennes E, Loriot Y, Soria JC. Ferté C, et al. Invest New Drugs. 2009 Dec;27(6):583-5. doi: 10.1007/s10637-009-9227-7. Epub 2009 Feb 17. Invest New Drugs. 2009. PMID: 19221694

3

[Clinical equipoise and randomised clinical trials in oncology].

Ferté C, Hollebecque A, Salleron J, Penel N. Ferté C, et al. Bull Cancer. 2009 Jun;96(6):727-31. doi: 10.1684/bdc.2009.0880. Bull Cancer. 2009. PMID: 19470421 French.

4

Reversible cardiogenic shock following 5-fluorouracil infusion.

Ferté C, Gomez Roca C, Loriot Y, Bahleda R, Moldovan C, Cohen A, Izzedine H, Soria JC, Ederhy S. Ferté C, et al. Invest New Drugs. 2010 Aug;28(4):531-3. doi: 10.1007/s10637-009-9271-3. Epub 2009 Jun 5. Invest New Drugs. 2010. PMID: 19499187

5

Development and validation of a bedside score to predict early death in cancer of unknown primary patients.

Penel N, Negrier S, Ray-Coquard I, Ferte C, Devos P, Hollebecque A, Sawyer MB, Adenis A, Seve P. Penel N, et al. Among authors: ferte c. PLoS One. 2009 Aug 3;4(8):e6483. doi: 10.1371/journal.pone.0006483. PLoS One. 2009. PMID: 19649260 Free PMC article.

6

Dysphonia induced by vascular endothelium growth factor/vascular endothelium growth factor receptor inhibitors.

Hartl DM, Ferté C, Loriot Y, Gomez Roca C, Bahleda R, Moldovan C, Mir O, Soria JC. Hartl DM, et al. Among authors: ferte c. Invest New Drugs. 2010 Dec;28(6):884-6. doi: 10.1007/s10637-009-9314-9. Epub 2009 Sep 16. Invest New Drugs. 2010. PMID: 19756374 No abstract available.

7

Pemetrexed-induced pneumonitis: a case report.

Loriot Y, Ferte C, Gomez-Roca C, Moldovan C, Bahleda R, Wislez M, Cadranel J, Soria JC. Loriot Y, et al. Among authors: ferte c. Clin Lung Cancer. 2009 Sep;10(5):364-6. doi: 10.3816/CLC.2009.n.050. Clin Lung Cancer. 2009. PMID: 19808196

8

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.

Ferté C, André F, Soria JC. Ferté C, et al. Nat Rev Clin Oncol. 2010 Jul;7(7):367-80. doi: 10.1038/nrclinonc.2010.84. Epub 2010 Jun 15. Nat Rev Clin Oncol. 2010. PMID: 20551944 Review.

9

Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials.

Ferte C, Soria JC, Penel N. Ferte C, et al. PLoS One. 2011 Mar 2;6(3):e16633. doi: 10.1371/journal.pone.0016633. PLoS One. 2011. PMID: 21415927 Free PMC article.

10

Natural history, management and pharmacokinetics of everolimus-induced-oral ulcers: insights into compliance issues.

Ferté C, Paci A, Zizi M, Gonzales DB, Goubar A, Gomez-Roca C, Massard C, Sahmoud T, André F, Soria JC. Ferté C, et al. Eur J Cancer. 2011 Oct;47(15):2249-55. doi: 10.1016/j.ejca.2011.03.017. Epub 2011 Apr 12. Eur J Cancer. 2011. PMID: 21489779 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters